AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR

摘要

The invention relates to substituted ß<SUP>3</SUP>-Phe-Trp-ß<SUP>3</SUP> -Lys-beta-tri-peptides and derivatives thereof, a process for their preparation, pharmaceutical preparations which contain these compounds which are agonists/antagonists of somatostatin receptors, as active agents for the treatment of disorders which can be influenced by a modulation of somatostatin receptor activity, in particular somatostatin receptor sst<SUB>4</SUB> activity, by the compounds of the invention.